Abstract

BackgroundAge-related macular degeneration (AMD) is a devastating eye disease causing irreversible vision loss in the elderly. Retinal pigment epithelium (RPE), the primary cell type that is afflicted in AMD, undergoes programmed cell death in the late stages of the disease. However, the exact mechanisms for RPE degeneration in AMD are still unresolved. The prevailing theories consider that each cell death pathway works independently and without regulation of each other. Building upon our previous work in which we induced a short burst of inflammasome activity in vivo, we now investigate the effects of prolonged inflammasome activity on RPE cell death mechanisms in rats.MethodsLong-Evans rats received three intravitreal injections of amyloid beta (Aβ), once every 4 days, and were sacrificed at day 14. The vitreous samples were collected to assess the levels of secreted cytokines. The inflammasome activity was evaluated by both immunohistochemistry and western blot. The types of RPE cell death mechanisms were determined using specific cell death markers and morphological characterizations.ResultsWe found robust inflammasome activation evident by enhanced caspase-1 immunoreactivity, augmented NF-κB nuclear translocalization, increased IL-1β vitreal secretion, and IL-18 protein levels. Moreover, we observed elevated proteolytic cleavage of caspase-3 and gasdermin D, markers for apoptosis and pyroptosis, respectively, in RPE-choroid tissues. There was also a significant reduction in the anti-apoptotic factor, X-linked inhibitor of apoptosis protein, consistent with the overall changes of RPE cells. Morphological analysis showed phenotypic characteristics of pyroptosis including RPE cell swelling.ConclusionsOur data suggest that two cell death pathways, pyroptosis and apoptosis, were activated in RPE cells after exposure to prolonged inflammasome activation, induced by a drusen component, Aβ. The involvement of two distinct cell death pathways in RPE sheds light on the potential interplay between these pathways and provides insights on the future development of therapeutic strategies for AMD.

Highlights

  • Age-related macular degeneration (AMD) is a devastating eye disease causing irreversible vision loss in the elderly

  • We found monocytes chemoattractant protein 1 (MCP-1), chemokine (C-X-C motif ) ligand 1 (GRO/KC), vascular endothelial growth factor (VEGF), and macrophage inflammatory protein 3 alpha (MIP-3α) were increased more than 50% in the Amyloid beta (Aβ) injected eyes compared to those in the reverse Aβ injected eyes (Fig. 1)

  • In conclusion, we have demonstrated the activation of two distinct cell death pathways in Retinal pigment epithelium (RPE) following prolonged pro-inflammation induced by drusen component, Aβ

Read more

Summary

Introduction

Age-related macular degeneration (AMD) is a devastating eye disease causing irreversible vision loss in the elderly. Retinal pigment epithelium (RPE), the primary cell type that is afflicted in AMD, undergoes programmed cell death in the late stages of the disease. Age-related macular degeneration (AMD) is a neurodegenerative disease that strikes the macula, causing irreversible blindness to people over the age of 50 in industrialized countries. The accumulation of drusen both in size and in number has become a hallmark of AMD progression As it progresses, AMD transitions from early benign stages into advanced vision-threatening stages, presenting with either choroidal neovascularization (CNV, wet form) and/or geographic atrophy (GA, dry form). Retinal pigment epithelium (RPE) cell death and secondary photoreceptor degeneration are two signature changes that lead to central vision loss in GA, the advanced stage of dry AMD. It is paramount to understand the fundamental mechanisms underlying these devastating impacts to the retina, especially the ones that undermine RPE health

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call